Skip to main content
Clinical Trials/NCT03255785
NCT03255785
Completed
Not Applicable

A Prospective Evaluation of Mild to Moderate Open-Angle Glaucoma Subjects With Cataract Treated With Cataract Surgery Plus One Trabecular Micro-bypass Stent and One Suprachoroidal Stent

Glaukos Corporation1 site in 1 country15 target enrollmentMay 1, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Glaucoma, Open-Angle
Sponsor
Glaukos Corporation
Enrollment
15
Locations
1
Primary Endpoint
20% IOP reduction from baseline
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Open Angle Glaucoma Subjects with Cataract treated with Cataract Surgery plus one trabecular micro-bypass stent and one suprachoroidal stent

Registry
clinicaltrials.gov
Start Date
May 1, 2018
End Date
December 3, 2019
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Clinically significant cataract requiring surgery Primary open-angle or pseudoexfoliative glaucoma Visual field defects no worse than -12dB Subject on two ocular hypotensive medications at screening Medicated IOP at screening between 18 and 30 mm Hg Normal iridocorneal anatomy Absence of peripheral anterior synechiae

Exclusion Criteria

  • Monocular subjects or those with wore than 20/200 vision in fellow eye Prior stent implantation, incision glaucoma surgery, or laser trabeculoplasty in study eye Traumatic, uveitic, or neovascular glaucoma

Outcomes

Primary Outcomes

20% IOP reduction from baseline

Time Frame: Month 12

IOP measured via Goldmann tonometry in mm Hg and compared to baseline IOP

Secondary Outcomes

  • IOP less than or equal to 18 mm Hg(Month 12)

Study Sites (1)

Loading locations...

Similar Trials